MYD88 and tuberculosis: Although IL-1 was predicted to be activated downstream of the TLR-MyD88 signalling cascade, we failed to detect any difference in the level of IL-1β following MyD88 inhibition (Fig. 6), suggesting other immunological pathways are also involved in mediating the inflammatory response in TB-IRIS.